Fulcrum Therapeutics (FULC) Assets Average (2019 - 2026)
Fulcrum Therapeutics (FULC) has disclosed Assets Average for 7 consecutive years, with $290.6 million as the latest value for Q4 2025.
- Quarterly Assets Average rose 7.67% to $290.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $290.6 million through Dec 2025, up 7.67% year-over-year, with the annual reading at $313.5 million for FY2025, 20.95% up from the prior year.
- Assets Average for Q4 2025 was $290.6 million at Fulcrum Therapeutics, up from $221.8 million in the prior quarter.
- The five-year high for Assets Average was $310.7 million in Q2 2023, with the low at $143.0 million in Q1 2021.
- Average Assets Average over 5 years is $241.7 million, with a median of $245.2 million recorded in 2021.
- The sharpest move saw Assets Average surged 80.49% in 2021, then decreased 22.6% in 2025.
- Over 5 years, Assets Average stood at $245.3 million in 2021, then decreased by 3.27% to $237.2 million in 2022, then increased by 13.08% to $268.3 million in 2023, then increased by 0.59% to $269.9 million in 2024, then increased by 7.67% to $290.6 million in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $290.6 million, $221.8 million, and $235.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.